C12P   1/00  \	0	0	4B064	C12P   1/00	469	微生物または酵素を使用してのグループＣ１２Ｐ３／００〜Ｃ１２Ｐ３９／００に分類されない化合物または組成物の製造；微生物または酵素を使用しての化合物または組成物の製造方法一般［３］	Preparation of compounds or compositions, not provided for in groups C12P 3/00-C12P 39/00, by using micro-organisms or enzymes; General processes for the preparation of compounds or compositions by using micro-organisms or enzymes [3]
C12P   1/00  A	0	0	4B064	C12P   1/00	448	酵素分解によるもの	Using enzyme decomposition
C12P   1/00  Z	0	0	4B064	C12P   1/00	957	その他のもの	Others
C12P   1/02  \	1	1	4B064	C12P   1/02	448	菌類の使用によるもの［３］	by using fungi [3]
C12P   1/02  A	1	0	4B064	C12P   1/02	310	糸状菌由来の抗生物質	Antibiotics (of mould origin)
C12P   1/02  B	1	0	4B064	C12P   1/02	164	担子菌由来の抗生物質	Antibiotics (of basidiomycete origin)
C12P   1/02  C	1	0	4B064	C12P   1/02	105	不完全菌由来の抗生物質	Antibiotics (of  Fungi Imperfecti origin)
C12P   1/02  D	1	0	4B064	C12P   1/02	59	酵母由来の抗生物質	Antibiotics (of enzyme origin)
C12P   1/02  Z	1	0	4B064	C12P   1/02	492	その他のもの	Others
C12P   1/04  \	1	1	4B064	C12P   1/04	563	細菌の使用によるもの［３］	by using bacteria [3]
C12P   1/04  A	1	0	4B064	C12P   1/04	513	抗生物質	Antibiotics
C12P   1/04  Z	1	0	4B064	C12P   1/04	727	その他のもの	Others
C12P   1/06  \	1	1	4B064	C12P   1/06	771	放線菌の使用によるもの［３］	by using actinomycetales [3]
C12P   1/06  A	1	0	4B064	C12P   1/06	1698	抗生物質	Antibiotics
C12P   1/06  Z	1	0	4B064	C12P   1/06	188	その他のもの	Others
C12P   3/00  \	0	0	4B064	C12P   3/00	160	二酸化炭素を除く無機化合物または元素の製造［３］	Preparation of elements or inorganic compounds except carbon dioxide [3]
C12P   3/00  A	0	0	4B064	C12P   3/00	90	バクテリア・リーチングによるもの	From bacteria leaching
C12P   3/00  Z	0	0	4B064	C12P   3/00	458	その他のもの	Others
C12P   5/00  \	0	0	4B064	C12P   5/00	336	炭化水素の製造［３］	Preparation of hydrocarbons [3]
C12P   5/02  \	1	1	4B064	C12P   5/02	690	非環式のもの［３］	acyclic [3]
C12P   7/00  \	0	0	4B064	C12P   7/00	210	酸素原子を含む有機化合物の製造［３］	Preparation of oxygen-containing organic compounds [3]
C12P   7/02  \	1	1	4B064	C12P   7/02	709	水酸基を有するもの［３］	containing a hydroxy group [3]
C12P   7/04  \	2	2	4B064	C12P   7/04	625	非環式のもの［３］	acyclic [3]
C12P   7/06  \	3	3	4B064	C12P   7/06	1578	エタノール，すなわち非飲料のもの［３］	Ethanol, i.e. non-beverage [3]
C12P   7/08  \	4	4	4B064	C12P   7/08	399	副産物としてまたは廃棄物またはセルロース物質の基質からの製造［３］	produced as by-product or from waste or cellulosic material substrate [3]
C12P   7/10  \	5	5	4B064	C12P   7/10	500	セルロース物質を含む基質［３］	substrate containing cellulosic material [3]
C12P   7/12  \	5	5	4B064	C12P   7/12	11	亜硫酸廃液または柑橘類の廃棄物を含む基質［３］	substrate containing sulfite waste liquor or citrus waste [3]
C12P   7/14  \	4	4	4B064	C12P   7/14	23	多段発酵；微生物の多段型または微生物の再使用［３］	Multiple stages of fermentation; Multiple types of micro-organisms or reuse for micro-organisms [3]
C12P   7/16  \	3	3	4B064	C12P   7/16	339	ブタノール［３］	Butanols [3]
C12P   7/18  \	3	3	4B064	C12P   7/18	754	多価アルコール［３］	polyhydric [3]
C12P   7/20  \	4	4	4B064	C12P   7/20	108	グリセロール［３］	Glycerol [3]
C12P   7/22  \	2	2	4B064	C12P   7/22	710	芳香族のもの［３］	aromatic [3]
C12P   7/24  \	1	1	4B064	C12P   7/24	366	カルボニル基を含むもの［３］	containing a carbonyl group [3]
C12P   7/26  \	2	2	4B064	C12P   7/26	569	ケトン［３］	Ketones [3]
C12P   7/28  \	3	3	4B064	C12P   7/28	176	アセトンを含む生成物［３］	Acetone-containing products [3]
C12P   7/30  \	4	4	4B064	C12P   7/30	3	水以外の無機化合物を含む基質から製造したもの［３］	produced from substrate containing inorganic compounds other than water [3]
C12P   7/32  \	4	4	4B064	C12P   7/32	0	無機窒素源を含む基質から製造したもの［３］	produced from substrate containing inorganic nitrogen source [3]
C12P   7/34  \	4	4	4B064	C12P   7/34	1	窒素源として蛋白質を含む基質から製造したもの［３］	produced from substrate containing protein as nitrogen source [3]
C12P   7/36  \	4	4	4B064	C12P   7/36	5	穀物または穀類を含む基質から製造したもの［３］	produced from substrate containing grain or cereal material [3]
C12P   7/38  \	3	3	4B064	C12P   7/38	44	シクロペンタノンまたはシクロペンタジオンを含む生成物［３］	Cyclopentanone- or cyclopentadione- containing products [3]
C12P   7/40  \	1	1	4B064	C12P   7/40	1244	カルボキシル基を含むもの［３］	containing a carboxyl group [3]
C12P   7/42  \	2	2	4B064	C12P   7/42	1193	ヒドロキシカルボン酸［３］	Hydroxy carboxylic acids [3]
C12P   7/44  \	2	2	4B064	C12P   7/44	510	ポリカルボン酸［３］	Polycarboxylic acids [3]
C12P   7/46  \	3	3	4B064	C12P   7/46	563	４以下の炭素原子をもつジカルボン酸，例．フマル酸，マレイン酸［３］	Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid [3]
C12P   7/48  \	3	3	4B064	C12P   7/48	252	トリカルボン酸，例．クエン酸［３］	Tricarboxylic acids, e.g. citric acid [3]
C12P   7/50  \	3	3	4B064	C12P   7/50	170	ケト基をもつもの，例．２―ケトグルタル酸［３］	having keto groups, e.g. 2-ketoglutaric acid [3]
C12P   7/52  \	2	2	4B064	C12P   7/52	239	プロピオン酸；酪酸［３］	Propionic acid; Butyric acids [3]
C12P   7/54  \	2	2	4B064	C12P   7/54	292	酢酸［３］	Acetic acid [3]
C12P   7/56  \	2	2	4B064	C12P   7/56	799	乳酸［３］	Lactic acid [3]
C12P   7/58  \	2	2	4B064	C12P   7/58	175	アルドン酸，ケトアルドン酸，または糖酸（ウロン酸Ｃ１２Ｐ１９／００）［３］	Aldonic, ketoaldonic or saccharic acids (uronic acids C12P 19/00) [3]
C12P   7/60  \	3	3	4B064	C12P   7/60	90	２―ケトグロン酸［３］	2-Ketogulonic acid [3]
C12P   7/62  \	1	1	4B064	C12P   7/62	2063	カルボン酸エステル［２０２２．０１］	Carboxylic acid esters [3, 2006.01, 2022.01]
C12P   7/625  \	2	2	4B064	C12P   7/625	659	ヒドロキシカルボン酸のポリエステル［２０２２．０１］	Polyesters of hydroxy carboxylic acids [2022.01]
C12P   7/64  \	1	1	4B064	C12P   7/64	2452	脂肪；脂肪油；エステル型ろう；高級脂肪酸，すなわちカルボキシル基に連続して結合する鎖部に少なくとも７個の炭素原子を含むもの；酸化油または脂肪［２０２２．０１］	Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats [3, 2006.01, 2022.01]
C12P   7/6409  \	2	2	4B064	C12P   7/6409	278	脂肪酸［２０２２．０１］	Fatty acids [2022.01]
C12P   7/6418  \	3	3	4B064	C12P   7/6418	190	脂肪酸エステルの加水分解によるもの［２０２２．０１］	by hydrolysis of fatty acid esters [2022.01]
C12P   7/6427  \	3	3	4B064	C12P   7/6427	448	多価不飽和脂肪酸［ＰＵＦＡ］，すなわち，炭素骨格に２以上の二重結合をもつもの［２０２２．０１］	Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone [2022.01]
C12P   7/6431  \	4	4	4B064	C12P   7/6431	43	リノール酸［１８：２［ｎー６］］［２０２２．０１］	Linoleic acids [18:2[n-6]] [2022.01]
C12P   7/6432  \	4	4	4B064	C12P   7/6432	107	エイコサペンタエン酸［ＥＰＡ］［２０２２．０１］	Eicosapentaenoic acids [EPA] [2022.01]
C12P   7/6434  \	4	4	4B064	C12P   7/6434	142	ドコサヘキサエン酸［ＤＨＡ］［２０２２．０１］	Docosahexenoic acids [DHA] [2022.01]
C12P   7/6436  \	2	2	4B064	C12P   7/6436	180	脂肪酸エステル［２０２２．０１］	Fatty acid esters [2022.01]
C12P   7/6445  \	3	3	4B064	C12P   7/6445	126	グリセリド［２０２２．０１］	Glycerides [2022.01]
C12P   7/6454  \	4	4	4B064	C12P   7/6454	122	エステル化によるもの［２０２２．０１］	by esterification [2022.01]
C12P   7/6458  \	4	4	4B064	C12P   7/6458	174	エステル転移によるもの，例．エステル交換，エステル置換，アルコール分解または酸分解［２０２２．０１］	by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis [2022.01]
C12P   7/6463  \	4	4	4B064	C12P   7/6463	425	グリセリドを産生する微生物から得られるもの，例．単細胞油［２０２２．０１］	obtained from glyceride producing microorganisms, e.g. single cell oil [2022.01]
C12P   7/6472  \	4	4	4B064	C12P   7/6472	523	多価不飽和脂肪酸［ＰＵＦＡ］残基を有するもの，すなわち炭素骨格に２以上の二重結合をもつもの［２０２２．０１］	containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone [2022.01]
C12P   7/6481  \	4	4	4B064	C12P   7/6481	55	ホスホグリセリド（炭素数が７未満のカルボン酸を有するホスホグリセリドＣ１２Ｐ７／６２）［２０２２．０１］	Phosphoglycerides (phosphoglycerides having carboxylic acids with less than seven carbon atoms C12P 7/62) [2022.01]
C12P   7/649  \	3	3	4B064	C12P   7/649	134	バイオディーゼル，すなわち脂肪酸アルキルエステル［２０２２．０１］	Biodiesel, i.e. fatty acid alkyl esters [2022.01]
C12P   7/66  \	1	1	4B064	C12P   7/66	158	キノイド構造をもつもの［３］	containing the quinoid structure [3]
C12P   7/66  A	1	0	4B064	C12P   7/66	222	補酵素Ｑ	Coenzyme Q
C12P   7/66  Z	1	0	4B064	C12P   7/66	134	その他のもの	Others
C12P   9/00  \	0	0	4B064	C12P   9/00	406	金属原子，またはＨ，Ｎ，Ｃ，Ｏ，Ｓまたはハロゲン以外の原子を含む有機化合物の製造［３］	Preparation of organic compounds containing a metal or atom other than H, N, C, O, S, or halogen [3]
C12P  11/00  \	0	0	4B064	C12P  11/00	265	硫黄原子を含む有機化合物の製造［３］	Preparation of sulfur-containing organic compounds [3]
C12P  13/00  \	0	0	4B064	C12P  13/00	1694	窒素原子を含む有機化合物の製造［３］	Preparation of nitrogen-containing organic compounds [3]
C12P  13/02  \	1	1	4B064	C12P  13/02	914	アミド，例．クロラムフェニコール［３］	Amides, e.g. chloramphenicol [3]
C12P  13/04  \	1	1	4B064	C12P  13/04	1657	α―またはβ―アミノ酸［３］	Alpha- or beta-amino acids [3]
C12P  13/06  \	2	2	4B064	C12P  13/06	325	アラニン；ロイシン；イソロイシン；セリン；ホモセリン［３］	Alanine; Leucine; Isoleucine; Serine; Homoserine [3]
C12P  13/06  A	2	0	4B064	C12P  13/06	185	アラニン	Alanine
C12P  13/06  B	2	0	4B064	C12P  13/06	145	ロイシン	Leucine
C12P  13/06  C	2	0	4B064	C12P  13/06	216	イソロイシン	Isoleucine
C12P  13/06  D	2	0	4B064	C12P  13/06	165	セリン	Serine
C12P  13/06  E	2	0	4B064	C12P  13/06	55	ホモセリン	Homeserine
C12P  13/06  Z	2	0	4B064	C12P  13/06	44	その他のもの	Others
C12P  13/08  \	2	2	4B064	C12P  13/08	466	リジン；ジアミノピメリン酸；トレオニン；バリン［３］	Lysine; Diaminopimelic acid; Threonine; Valine [3]
C12P  13/08  A	2	0	4B064	C12P  13/08	589	リジン	Lysine
C12P  13/08  B	2	0	4B064	C12P  13/08	18	ジアミノピメリン酸	Diaminopimelic acid
C12P  13/08  C	2	0	4B064	C12P  13/08	336	トレオニン	Threonine
C12P  13/08  D	2	0	4B064	C12P  13/08	178	バリン	Valine
C12P  13/08  Z	2	0	4B064	C12P  13/08	34	その他のもの	Others
C12P  13/10  \	2	2	4B064	C12P  13/10	74	シトルリン；アルギニン；オルニチン［３］	Citrulline; Arginine; Ornithine [3]
C12P  13/10  A	2	0	4B064	C12P  13/10	57	シトルリン	Citrulline
C12P  13/10  B	2	0	4B064	C12P  13/10	187	アルギニン	Arginine
C12P  13/10  C	2	0	4B064	C12P  13/10	94	オルニチン	Ornithine
C12P  13/10  Z	2	0	4B064	C12P  13/10	9	その他のもの	Others
C12P  13/12  \	2	2	4B064	C12P  13/12	82	メチオニン；システイン；シスチン［３］	Methionine; Cysteine; Cystine [3]
C12P  13/12  A	2	0	4B064	C12P  13/12	206	メチオニン	Methionine
C12P  13/12  B	2	0	4B064	C12P  13/12	177	システイン	Cycteine
C12P  13/12  C	2	0	4B064	C12P  13/12	44	シスチン	Cyctine
C12P  13/12  Z	2	0	4B064	C12P  13/12	55	その他のもの	Others
C12P  13/14  \	2	2	4B064	C12P  13/14	296	グルタミン酸；グルタミン［３］	Glutamic acid; Glutamine [3]
C12P  13/14  A	2	0	4B064	C12P  13/14	346	生産菌	Productive bacteria
C12P  13/14  B	2	0	4B064	C12P  13/14	124	転換，ＣＮ源	Conversion, CN source
C12P  13/14  C	2	0	4B064	C12P  13/14	109	分離，精製	Separation, refining
C12P  13/14  D	2	0	4B064	C12P  13/14	82	添加薬剤	Added medicinals
C12P  13/14  E	2	0	4B064	C12P  13/14	86	培養条件	Culture condition
C12P  13/14  Z	2	0	4B064	C12P  13/14	55	その他のもの	Others
C12P  13/16  \	3	3	4B064	C12P  13/16	44	界面活性剤，脂肪酸または脂肪酸エステル，すなわち．カルボキシル基またはカルボン酸エステル基に連続して結合する鎖部に少なくとも７個の炭素原子を有するもの，を使用するもの［３］	using surfactants, fatty acids or fatty acid esters, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group or a carboxyl ester group [3]
C12P  13/18  \	3	3	4B064	C12P  13/18	52	ビオチンまたはその誘導体を使用するもの［３］	using biotin or its derivatives [3]
C12P  13/20  \	2	2	4B064	C12P  13/20	223	アスパラギン酸；アスパラギン［３］	Aspartic acid; Asparagine [3]
C12P  13/22  \	2	2	4B064	C12P  13/22	645	トリプトファン；チロシン；フェニルアラニン；３，４―ジヒドロキシフェニルアラニン［３］	Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine [3]
C12P  13/22  A	2	0	4B064	C12P  13/22	375	トリプトファン	Tryptophan
C12P  13/22  B	2	0	4B064	C12P  13/22	110	チロシン	Tyrosine
C12P  13/22  C	2	0	4B064	C12P  13/22	393	フェニルアラニン	Phenylalanine
C12P  13/22  D	2	0	4B064	C12P  13/22	47	３．４−ジヒドロキシフェニルアラニン	3.4-Dihydroxyphenylalanine
C12P  13/22  Z	2	0	4B064	C12P  13/22	27	その他のもの	Others
C12P  13/24  \	2	2	4B064	C12P  13/24	119	プロリン；ヒドロキシプロリン；ヒスチジン［３］	Proline; Hydroxyproline; Histidine [3]
C12P  13/24  A	2	0	4B064	C12P  13/24	125	プロリン；ヒドロキシプロリン	Proline; Hydroxyproline
C12P  13/24  C	2	0	4B064	C12P  13/24	111	ヒスチジン	Histidine
C12P  13/24  Z	2	0	4B064	C12P  13/24	14	その他のもの	Others
C12P  15/00  \	0	0	4B064	C12P  15/00	194	３個以上の縮合炭素環を含む有機化合物の製造［３］	Preparation of compounds containing at least three condensed carbocyclic rings [3]
C12P  17/00  \	0	0	4B064	C12P  17/00	186	異項原子としてＯ，Ｎ，Ｓ，Ｓｅ，またはＴｅのみをもつ複素環式化合物の製造（Ｃ１２Ｐ１３／０４〜Ｃ１２Ｐ１３／２４が優先）［３］	Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms (C12P 13/04-C12P 13/24 take precedence) [3]
C12P  17/02  \	1	1	4B064	C12P  17/02	464	異項原子として酸素原子のみのもの［３］	Oxygen as only ring hetero atoms [3]
C12P  17/04  \	2	2	4B064	C12P  17/04	545	５員環をもつもの，例．グリセオフルビン［３］	containing a five-membered hetero ring, e.g. griseofulvin [3]
C12P  17/06  \	2	2	4B064	C12P  17/06	911	６員環をもつもの，例．フルオレセイン［３］	containing a six-membered hetero ring, e.g. fluorescein [3]
C12P  17/08  \	2	2	4B064	C12P  17/08	205	７員以上の環の複素環をもつもの，例．ゼアラレノン，マクロライドアグリコン［３］	containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons [3]
C12P  17/10  \	1	1	4B064	C12P  17/10	612	異項原子として窒素原子のみのもの［３］	Nitrogen as only ring hetero atom [3]
C12P  17/12  \	2	2	4B064	C12P  17/12	552	６員環をもつもの［３］	containing a six-membered hetero ring [3]
C12P  17/14  \	1	1	4B064	C12P  17/14	174	異項原子が窒素原子または酸素原子であり，かつ同一環内に２以上の異なる異項原子をもつもの［３］	Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring [3]
C12P  17/16  \	1	1	4B064	C12P  17/16	532	２以上の複素環をもつもの［３］	containing two or more hetero rings [3]
C12P  17/18  \	1	1	4B064	C12P  17/18	1175	２以上の複素環が互いに縮合または共通の炭素環と縮合した構造をもつもの，例．リファマイシン［３］	containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin [3]
C12P  17/18  A	1	0	4B064	C12P  17/18	181	異項原子がＮ１個の縮合複素環	Condensed hetero rings with N1 hetero atoms
C12P  17/18  B	1	0	4B064	C12P  17/18	364	異項原子がＮ２個以上の縮合複素環	Condensed hetero rings with N2 or more hetero atoms
C12P  17/18  C	1	0	4B064	C12P  17/18	417	異項原子としてＮとＯのみを含む縮合複素環	Condensed hetero rings having only N and O as hetero atoms
C12P  17/18  D	1	0	4B064	C12P  17/18	460	異項原子としてＯのみを含む縮合複素環	Condensed hetero rings having only  O as hetero atoms
C12P  17/18  Z	1	0	4B064	C12P  17/18	127	その他のもの	Others
C12P  19/00  \	0	0	4B064	C12P  19/00	901	糖類基を含む化合物の製造（ケトアルドン酸Ｃ１２Ｐ７／５８）［３］	Preparation of compounds containing saccharide radicals (ketoaldonic acids C12P  7/58)
C12P  19/02  \	1	1	4B064	C12P  19/02	1226	単糖類［３］	Monosaccharides [3]
C12P  19/04  \	1	1	4B064	C12P  19/04	979	多糖類，すなわち６以上の糖類基がグリコシド結合によって互いに結合した化合物［３］	Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds [3]
C12P  19/04  A	1	0	4B064	C12P  19/04	230	担子菌を除く菌類からのもの	Of fungus origin (excluding basidiomycete)
C12P  19/04  B	1	0	4B064	C12P  19/04	251	担子菌からのもの	Of  basidiomycete origin
C12P  19/04  C	1	0	4B064	C12P  19/04	967	細菌，例．放線菌，からのもの	Of bacteria origin (including ray fungus)
C12P  19/04  Z	1	0	4B064	C12P  19/04	599	その他からのもの	Of other origin
C12P  19/06  \	2	2	4B064	C12P  19/06	155	キサンタン，すなわちキサントモナス型のヘテロ多糖類［３］	Xanthan, i.e. Xanthomonas-type heteropolysaccharides [3]
C12P  19/08  \	2	2	4B064	C12P  19/08	39	デキストラン［３］	Dextran [3]
C12P  19/10  \	2	2	4B064	C12P  19/10	30	プルラン［３］	Pullulan [3]
C12P  19/12  \	1	1	4B064	C12P  19/12	571	二糖類［３］	Disaccharides [3]
C12P  19/14  \	1	1	4B064	C12P  19/14	348	カルボヒドラーゼの作用による製造，例．α―アミラーゼによるもの［３］	produced by the action of a carbohydrase, e.g. by alpha-amylase [3]
C12P  19/14  A	1	0	4B064	C12P  19/14	901	セルロース性物質を基質とするもの	Having cellulose substance as matrix
C12P  19/14  Z	1	0	4B064	C12P  19/14	909	その他のもの	Others
C12P  19/16  \	1	1	4B064	C12P  19/16	265	α−１，６−グルコシダーゼの作用による製造，例．アミロース，枝切りアミロペクチン［３］	produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin [3]
C12P  19/18  \	1	1	4B064	C12P  19/18	775	グリコシルトランスフェラーゼの作用による製造，例．α―，β―，またはγ―シクロデキストリン［３］	produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins [3]
C12P  19/20  \	1	1	4B064	C12P  19/20	214	エクソ―１，４―α―グルコシダーゼの作用による製造，例．デキストロース［３］	produced by the action of an exo-1, 4 alpha-glucosidase, e.g. dextrose [3]
C12P  19/22  \	1	1	4B064	C12P  19/22	186	β―アミラーゼの作用による製造，例．麦芽糖［３］	produced by the action of a beta-amylase, e.g. maltose [3]
C12P  19/24  \	1	1	4B064	C12P  19/24	285	イソメラーゼの作用による製造，例．果糖［３］	produced by the action of an isomerase, e.g. fructose [3]
C12P  19/26  \	1	1	4B064	C12P  19/26	773	窒素を含む炭水化物の製造［３］	Preparation of nitrogen-containing carbohydrates [3]
C12P  19/28  \	2	2	4B064	C12P  19/28	211	Ｎ―グリコシド［３］	N-glycosides [3]
C12P  19/30  \	3	3	4B064	C12P  19/30	283	ヌクレオチド［３］	Nucleotides [3]
C12P  19/32  \	4	4	4B064	C12P  19/32	847	同一環内に２個の窒素原子を有する６員環を含む縮合環系をもつもの，例．プリンヌレオチド，ニコチンアミド―アデニンジヌクレオチド［３］	having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide [3]
C12P  19/34  \	4	4	4B064	C12P  19/34	268	ポリヌクレオチド，例．核酸，オリゴリボヌクレオチド［３］	Polynucleotides, e.g. nucleic acids, oligoribonucleotides [3]
C12P  19/34  A	4	0	4B064	C12P  19/34	801	遺伝子工学に関するもの	Related to genetic engineering
C12P  19/34  Z	4	0	4B064	C12P  19/34	321	その他のもの	Others
C12P  19/36  \	4	4	4B064	C12P  19/36	156	ジヌクレオチド，例．ニコチンアミド―アデニンジヌクレオチドホスフェート［３］	Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate [3]
C12P  19/38  \	3	3	4B064	C12P  19/38	228	ヌクレオシド［３］	Nucleosides [3]
C12P  19/40  \	4	4	4B064	C12P  19/40	551	同一環内に２個の窒素原子をもつ６員環を含む縮合環系をもつもの，例．プリンヌクレオシド［３］	having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides [3]
C12P  19/42  \	3	3	4B064	C12P  19/42	152	コバラミン，すなわちビタミンＢ↓１↓２，ＬＬＤ因子［３］	Cobalamins, i.e. vitamin B<sub>12</sub>, LLD factor [3]
C12P  19/44  \	1	1	4B064	C12P  19/44	853	Ｏ―グリコシドの製造，例．グルコシド［３］	Preparation of O-glycosides, e.g. glucosides [3]
C12P  19/46  \	2	2	4B064	C12P  19/46	44	シクロヘキシル基に結合する糖類基の酸素原子を持つもの，例．カスガマイシン［３］	having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin [3]
C12P  19/48  \	3	3	4B064	C12P  19/48	155	シクロヘキシル基が２個以上の窒素原子で置換されているもの，例．デストマイシン，ネアミン［３］	the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin [3]
C12P  19/50  \	4	4	4B064	C12P  19/50	39	シクロヘキシル基の隣接する炭素原子に酸素原子によってのみ結合する２個の糖類基をもつもの，例．アンブチロシン，リボスタマイシン［３］	having two saccharide radicals bound through only oxygen to adjacent ring carbon atoms of the cyclohexyl radical, e.g. ambutyrosin, ribostamycin [3]
C12P  19/52  \	5	5	4B064	C12P  19/52	18	３以上の糖類基をもつもの，例．ネオマイシン，リビドマイシン［３］	containing three or more saccharide radicals, e.g. neomycin, lividomycin [3]
C12P  19/54  \	3	3	4B064	C12P  19/54	57	シクロヘキシル基が２以上の「図」基の窒素原子と直接結合したもの，例．ストレプトマイシン［３］	the cyclohexyl radical being bound directly to a nitrogen atom of two or more [figure] radicals, e.g. streptomycin [3]
C12P  19/56  \	2	2	4B064	C12P  19/56	335	糖類基の酸素原子が３以上の炭素環をもつ縮合環系に直接結合するもの，例．ダウノマイシン，アドリアマイシン［３］	having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin [3]
C12P  19/58  \	2	2	4B064	C12P  19/58	82	糖類基の酸素原子が非糖類複素環式基に非環状炭素原子のみによって直接結合するもの，例．ブレオマイシン，フレオマイシン［３］	having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin [3]
C12P  19/60  \	2	2	4B064	C12P  19/60	266	糖類基の酸素原子が非糖類複素環式基または非糖類複素環式基を含む縮合環系と直接結合するもの，例．クメルマイシン，ノボビオシン［３］	having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin [3]
C12P  19/62  \	3	3	4B064	C12P  19/62	348	複素環が８員以上の環であり，異項環原子として酸素原子のみもつもの，例．エリスロマイシン，スピラマイシン，ナイスタチン［３］	the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin [3]
C12P  19/64  \	1	1	4B064	C12P  19/64	26	Ｓ―グリコシドの製造，例．リンコマイシン［３］	Preparation of S-glycosides, e.g. lincomycin [3]
C12P  21/00  \	0	0	4B064	C12P  21/00	3639	ペプチドまたは蛋白質の製造（単細胞菌体蛋白質Ｃ１２Ｎ１／００）［３］	Preparation of peptides or proteins (single-cell protein C12N 1/00) [3]
C12P  21/00  A	0	0	4B064	C12P  21/00	1357	構造未知のペプチドまたはたんぱく質の製造（Ｃ１２Ｐ２１／００Ｃ〜Ｃ１２Ｐ２１／００Ｌが優先）	Preparation of peptides or proteins with unknown structure (C to L take precedence)
C12P  21/00  B	0	0	4B064	C12P  21/00	724	微生物菌体からのたんぱく質の分離・精製（Ｃ１２Ｐ２１／００Ｃ〜Ｃ１２Ｐ２１／００Ｌが優先）	Separation, refining of protein from bacterial fungus (C to L take precedence)
C12P  21/00  C	0	0	4B064	C12P  21/00	2579	遺伝子工学に関するもの（Ｃ１２Ｐ２１／００Ｅ〜Ｃ１２Ｐ２１／００Ｌが優先）	Related to genetic engineering (E to L take precedence)
C12P  21/00  E	0	0	4B064	C12P  21/00	42	インシュリン	Insulin
C12P  21/00  F	0	0	4B064	C12P  21/00	262	インターフェロン	Interferon
C12P  21/00  G	0	0	4B064	C12P  21/00	18	グルタチオン	Glutathione
C12P  21/00  H	0	0	4B064	C12P  21/00	198	成長因子，成長ホルモン	Growth factors, growth hormones
C12P  21/00  K	0	0	4B064	C12P  21/00	213	リンホカイン，例．インターロイキン	Lymphokine (interleukin)
C12P  21/00  L	0	0	4B064	C12P  21/00	72	リンホトキシン，ＴＮＦ	Lymphotoxin, TNF
C12P  21/00  Z	0	0	4B064	C12P  21/00	210	その他	Others
C12P  21/02  \	1	1	4B064	C12P  21/02	6279	２以上のアミノ酸の結合順序が既知のもの，例．グルタチオン［３］	having a known sequence of two or more amino acids, e.g. glutathione [3]
C12P  21/02  A	1	0	4B064	C12P  21/02	1508	構造既知のペプチドまたはたんぱく質の製造（Ｃ１２Ｐ２１／０２Ｃ〜Ｃ１２Ｐ２１／０２Ｌが優先）	Preparation of peptides or proteins with known structure (C to M take precedence)
C12P  21/02  B	1	0	4B064	C12P  21/02	658	酵素合成作用によるペプチドの製造（Ｃ１２Ｐ２１／０２Ｃ〜Ｃ１２Ｐ２１／０２Ｌが優先）	Preparation of peptides using enzyme synthesis action (C to M take precedence)
C12P  21/02  C	1	0	4B064	C12P  21/02	19525	遺伝子工学に関するもの（Ｃ１２Ｐ２１／０２Ｅ〜Ｃ１２Ｐ２１／０２Ｌが優先）	Related to genetic engineering (E to M take precedence)
C12P  21/02  E	1	0	4B064	C12P  21/02	267	インシュリン	Insulin
C12P  21/02  F	1	0	4B064	C12P  21/02	426	インターフェロン	Interferon
C12P  21/02  G	1	0	4B064	C12P  21/02	148	グルタチオン	Glutathione
C12P  21/02  H	1	0	4B064	C12P  21/02	958	成長因子，成長ホルモン	Growth factors, growth hormones
C12P  21/02  K	1	0	4B064	C12P  21/02	635	リンホカイン，例．インターロイキン	Lymphokine (interleukin)
C12P  21/02  L	1	0	4B064	C12P  21/02	189	リンホトキシン，ＴＮＦ	Lymphotoxin, TNF
C12P  21/02  Z	1	0	4B064	C12P  21/02	419	その他	Others
C12P  21/04  \	2	2	4B064	C12P  21/04	394	環状または架橋のペプチドまたはポリペプチド，例．バシトラシン［２００６．０１］	Cyclic or bridged peptides or polypeptides e.g. bacitracin
C12P  21/06  \	1	1	4B064	C12P  21/06	1262	ペプチド結合の加水分解による製造，例．加水分解生成物［３］	produced by the hydrolysis of a peptide bond, e.g. hydrolysate products [3]
C12P  21/08  \	1	1	4B064	C12P  21/08	23323	モノクローナル抗体［５］	Monoclonal antibodies [5]
C12P  23/00  \	0	0	4B064	C12P  23/00	499	共役二重結合によって結合している少なくとも１０個の炭素原子を含む不飽和側鎖をもつシクロヘキセン環を含む化合物の製造，例．カロチン（複素環を含むものＣ１２Ｐ１７／００）［３］	Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing hetero-rings C12P 17/00) [3]
C12P  25/00  \	0	0	4B064	C12P  25/00	159	アロキサジンまたはイソアロキサジン核をもつ化合物の製造，例．リボフラビン［３］	Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin [3]
C12P  27/00  \	0	0	4B064	C12P  27/00	8	ジバン骨格を含む化合物の製造，例．ジベレリン［３］	Preparation of compounds containing a gibbane ring system, e.g. gibberellin [3]
C12P  29/00  \	0	0	4B064	C12P  29/00	156	ナフタセン骨格を含む化合物の製造，例．テトラサイクリン（Ｃ１２Ｐ１９／００が優先）［３］	Preparation of compounds containing a naphthacene ring system, e.g. tetracycline (C12P 19/00 takes precedence) [3]
C12P  31/00  \	0	0	4B064	C12P  31/00	55	互いにオルト位にある２個と，その側鎖の１個に対するオルト位に環に直接結合する少なくとも１つの酸素原子をもつ５員環を含有する化合物であって，その１個の側鎖は異種原子に対する３個の結合を有し，そのうち最大１個の結合はハロゲンに対する結合である炭素原子であって環に直接結合しないものを含み，他の側鎖は環に対してγ―位に結合する酸素原子を少なくとも１個持った化合物の製造，例．プロスタグランジン［３］	Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins [3]
C12P  33/00  \	0	0	4B064	C12P  33/00	306	ステロイドの製造［３］	Preparation of steroids
C12P  33/02  \	1	1	4B064	C12P  33/02	151	脱水素化；脱水酸基化［３］	Dehydrogenating; Dehydroxylating [3]
C12P  33/04  \	2	2	4B064	C12P  33/04	7	Ａ環からアリール環の生成［３］	Forming an aryl ring from A ring [3]
C12P  33/06  \	1	1	4B064	C12P  33/06	142	水酸化［３］	Hydroxylating [3]
C12P  33/08  \	2	2	4B064	C12P  33/08	64	１１位に［３］	at 11 position [3]
C12P  33/10  \	3	3	4B064	C12P  33/10	21	１１α―位に［３］	at 11alpha-position [3]
C12P  33/12  \	1	1	4B064	C12P  33/12	34	Ｄ環への作用［３］	Acting on D ring [3]
C12P  33/14  \	2	2	4B064	C12P  33/14	13	１６位の水酸化［３］	Hydroxylating at 16 position [3]
C12P  33/16  \	2	2	4B064	C12P  33/16	180	１７位への作用［３］	Acting at 17 position [3]
C12P  33/18  \	3	3	4B064	C12P  33/18	36	１７位の水酸化［３］	Hydroxylating at 17 position [3]
C12P  33/20  \	1	1	4B064	C12P  33/20	78	複素環をもつもの［３］	containing heterocyclic rings [3]
C12P  35/00  \	0	0	4B064	C12P  35/00	104	５―チア―１―アザビシクロ〔４．２．０〕オクタン環系をもつ化合物の製造，例．セファロスポリン［３］	Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin [3]
C12P  35/02  \	1	1	4B064	C12P  35/02	59	７位における置換基の脱アシル化によるもの［３］	by desacylation of the substituent in the 7 position [3]
C12P  35/04  \	1	1	4B064	C12P  35/04	84	７位における置換基のアシル化によるもの［３］	by acylation of the substituent in the 7 position [3]
C12P  35/06  \	1	1	4B064	C12P  35/06	96	セファロスポリンＣ；その誘導体［３］	Cephalosporin C; Derivatives thereof [3]
C12P  35/08  \	1	1	4B064	C12P  35/08	72	７位における２置換体［３］	disubstituted in the 7 position [3]
C12P  37/00  \	0	0	4B064	C12P  37/00	102	４―チア―１―アザビシクロ〔３．２．０〕ヘプタン環系をもつ化合物の製造，例．ペニシリン［３］	Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin [3]
C12P  37/02  \	1	1	4B064	C12P  37/02	12	フェニル酢酸，フェニル酢酸アミドまたはその誘導体の存在下［３］	in presence of phenylacetic acid or phenylacetamide or their derivatives [3]
C12P  37/04  \	1	1	4B064	C12P  37/04	54	６位の置換基のアシル化によるもの［３］	by acylation of the substituent in the 6 position [3]
C12P  37/06  \	1	1	4B064	C12P  37/06	64	６位の置換基の脱アシル化によるもの［３］	by desacylation of the substituent in the 6 position [3]
C12P  39/00  \	0	0	4B064	C12P  39/00	116	同一工程内で同時に異なった種の微生物を含む方法［３］	Processes involving micro-organisms of different genera in the same process, simultaneously [3]
C12P  41/00  \	0	0	4B064	C12P  41/00	972	酵素または微生物を利用してラセミ混合物から光学異性体を分離する方法［４］	Processes using enzymes or micro-organisms to separate optical isomers from a racemic mixture [4]
C12P  41/00  A	0	0	4B064	C12P  41/00	407	αアミノ酸，βアミノ酸またはそれらの誘導体を分離するもの	Separating a or b amino acid (including derivatives)
C12P  41/00  B	0	1	4B064	C12P  41/00	71	環の加水分解によるもの	By hydrolysis of the ring
C12P  41/00  C	0	0	4B064	C12P  41/00	352	Ｃ，Ｈ，Ｏ，ハロゲン以外の元素を含まないラセミ混合物からのもの	From racemic mixture not containing elements other than C, H, O, halogen
C12P  41/00  D	0	1	4B064	C12P  41/00	234	ラセミエステル混合物からのもの	From racemic ester mixture
C12P  41/00  E	0	2	4B064	C12P  41/00	201	環式ラセミ混合物からのもの	From ring racemic mixture
C12P  41/00  F	0	3	4B064	C12P  41/00	235	芳香族ラセミ混合物からのもの	From aromatic racemic mixture
C12P  41/00  G	0	3	4B064	C12P  41/00	66	非縮合炭素５員環ラセミ混合物からのもの	From non-condensed carbon five-membered racemic mixture
C12P  41/00  H	0	0	4B064	C12P  41/00	252	Ｎ含有ラセミ混合物からのもの（Ｃ１２Ｐ４１／００Ａ，Ｃ１２Ｐ４１／００Ｂ優先）	From racemic mixture containing N
C12P  41/00  J	0	1	4B064	C12P  41/00	344	環式ラセミ混合物からのもの	From ring racemic mixture
C12P  41/00  K	0	0	4B064	C12P  41/00	147	Ｃ，Ｈ，Ｏ，Ｎ，ハロゲン以外の元素含有ラセミ混合物からのもの	From racemic mixture containing elements other than C, H, O, N, halogen (salt is classified under matrix compound)
C12P  41/00  Z	0	0	4B064	C12P  41/00	207	その他のもの	Others
